CTKB
Cytek Biosciences Inc
5.70$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -58.4% | +56.8% | +113.1% | -84.9% | -106.3% | – | -3,709.3% | – | – | – | – | |
| – | -5.2% | +1.4% | +0.8% | +13.3% | -2.4% | +5.2% | +3.6% | +2.4% | -0.6% | -7.6% | +6.1% | – | |
| – | -1.5% | -0.5% | +26.8% | -1.4% | -0.7% | -5.3% | +2.4% | -17.0% | -2.0% | -12.0% | +9.8% | – | |
| – | – | – | +338.9% | -222.8% | – | – | -125.9% | – | – | – | -53.4% | – | |
| – | +12.1% | -60.2% | +93.1% | -32.7% | +11.8% | -5.8% | +85.3% | -58.5% | +52.8% | +116.6% | +2.2% | – | |
| – | -32.6% | -119.8% | – | -881.8% | +301.2% | – | -273.6% | – | -109.7% | +1,370.1% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +312.2% | -99.6% | +1,704.1% | +347.6% | -41.5% | +52.0% | -57.6% | – | +17.2% | -100.0% | – | – | |
| – | – | – | – | – | – | -131.3% | – | +56.6% | -178.3% | – | -137.4% | – | |
| – | +308.0% | – | -206.1% | +606.3% | -69.9% | +217.2% | -77.5% | – | -163.2% | – | -120.4% | – | |
| – | -87.5% | -62.2% | +480.9% | -277.9% | – | – | – | – | -113.6% | – | – | – | |
| – | – | -58.1% | +50.0% | +148.1% | -91.2% | -189.2% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.